2 news items
Takeda's Dengue Vaccine Gets WHO Approval, Eligible for UN Procurement
SNY
TAK
15 May 24
6–16 in settings with high dengue burden and transmission intensity.
Related
Takeda Announces U.S. FDA Approval Of Supplemental New Drug Application For ICLUSIG In Adult Patients With Newly Diagnosed Ph+ ALL
TAK
19 Mar 24
clinical trial in adults with newly diagnosed Ph+ ALL. The study, in which patients received either ICLUSIG or imatinib, plus reduced-intensity
- Prev
- 1
- Next